Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Medroxyprogesterone Acetate × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Endometrial Neoplasms 5 Endometrial Hyperplasia 2 Neoplasms 1 Menorrhagia 1 Leiomyoma 1

Interventions

pembrolizumab 35 Blood Specimen Collection 34 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 15 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Drug Therapy 11 Cisplatin 11 atezolizumab 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 10 Fluorouracil 9 Trastuzumab 8 Pemetrexed 8 Leucovorin 8 Cetuximab 8 pertuzumab 7 olaparib 7 Temozolomide 7 Oxaliplatin 7 Observation 7 Irinotecan 7 Interviews as Topic 7 Radiosurgery 6 Panitumumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06979596 2026-03-06

OMAHA-015

Merck Sharp & Dohme LLC

Phase 2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡